GSK collaborates with Merck for cancer immunotherapy

World |  News | 0 Comment | 06 Feb, 2019

GlaxoSmithKline and Merck KGaA, Darmstadt, Germany have announced that they have entered into a global strategic alliance to jointly develop and commercialise M7824 (bintrafusp alfa) M7824...Read more

Venus Concept brings Venus Heal to heal soft tissue injuries

World |  News | 0 Comment | 06 Feb, 2019

Venus Concept Ltd., an innovative global medical technology leader, announces the launch of its latest medical device, Venus Heal™. With over 11,000 systems installed worldwide, Venus...Read more

Dr. Benjamin Freedman earns STEM CELLS Young Investigator Award

World |  News | 0 Comment | 05 Feb, 2019

Benjamin “Beno” Freedman, Ph.D., is named STEM CELLS’s Young Investigator of 2018 for his groundbreaking work with organoids in studying kidney structure and disease. This...Read more

ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company

World |  News | 0 Comment | 05 Feb, 2019

ProteoNic Biotechnology BV has announced that it licensed its 2G UNic technology for boosting recombinant protein production to Eli Lilly and Company. Under the agreement, Lilly gains non-...Read more

CIRM approves $6M to study new treatment for Huntington's disease

World |  News | 0 Comment | 05 Feb, 2019

Following a California Institute for Regenerative Medicine (CIRM) Independent Citizens Oversight Committee meeting held last week, University of California, Irvine (UCI) researchers  h...Read more

OmniVision develops innovative smart dental mirror

World |  News | 0 Comment | 05 Feb, 2019

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, along with SMARTmirror, a developer of innovative dental products, has announced from MD&M West...Read more

Senseonics extends distribution agreement with Roche

World |  News | 0 Comment | 05 Feb, 2019

Senseonics Holdings, a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with dia...Read more

IQVIA to develop solutions for life sciences industry

World |  News | 0 Comment | 05 Feb, 2019

IQVIA has announced the launch of IQVIA Biotech and its new approach to delivering tailored clinical and commercial solutions for small biotech and biopharma companies. This solutions suit...Read more

Torque collaborates with Thermo Fisher for immunotherapy facility

World |  News | 0 Comment | 05 Feb, 2019

Torque, an immuno-oncology company developing first-in-class Deep Primed T Cell Therapeutics to direct immune power deep within the tumor microenvironment, and Thermo Fisher Scientific Inc....Read more

Fortress Biotech announces strategic partnership with Alexion Pharma

World |  News | 0 Comment | 04 Feb, 2019

Biopharma company, Fortress Biotech dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products has announced that Caelum Biosciences has signed a...Read more

Health systems must provide cancer screening, detection and diagnosis at all levels of care

World |  Opinion | 0 Comment | 04 Feb, 2019

Cancer is far from an equal-opportunity killer. In 2018 - 18.1 million new cases developed worldwide, while around 9.6 million people died from the disease. 70% of those deaths occurred in ...Read more

Alkermes announces rejection of ALKS 5461 NDA

World |  News | 0 Comment | 04 Feb, 2019

Alkermes plc has announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ALKS 5461 for the ...Read more

Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval

World |  News | 0 Comment | 01 Feb, 2019

Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of ADVAIR DISKUS. Wixel...Read more

Magnolia Medical announces $20M funding

World |  News | 0 Comment | 01 Feb, 2019

Magnolia Medical Technologies has announced a $20 million Series C financing round to scale the company’s infrastructure and market initiatives to meet the rapidly growing demand for ...Read more

J&J collaborates with MeiraGTx

World |  News | 0 Comment | 01 Feb, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced a worldwide collaboration and license agreement with MeiraGTx Holdings, a clinical-stage gene therapy company, to...Read more

FDA expands Lilly's ALIMTA Label

World |  News | 0 Comment | 01 Feb, 2019

Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed for injection) in combination with KEYTRUDA® (pembrolizumab...Read more

I Holland to conduct seminar on problems in tablet production

World |  News | 0 Comment | 31 Jan, 2019

I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets is pleased to announce that the company is hosting the ‘Ultimate Gui...Read more

Spero Therapeutics announces initiation of SPR720 Ph 1 Clinical Trial

World |  News | 0 Comment | 31 Jan, 2019

Spero Therapeutics,  a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacter...Read more